Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone.
Palmieri
G
G
Department of Molecular and Clinical Oncology and Endocrinology, School of Medicine, Federico II University, Naples, Italy.
Lastoria
S
S
Colao
A
A
Vergara
E
E
Varrella
P
P
Biondi
E
E
Selleri
C
C
Catalano
L
L
Lombardi
G
G
Bianco
A R
AR
Salvatore
M
M
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D012010:Red-Cell Aplasia, Pure / Q000150:complications / Q000188:drug therapy*; D013945:Thymoma / Q000150:complications / Q000188:drug therapy*; D013953:Thymus Neoplasms / Q000150:complications / Q000188:drug therapy*
D018931:Antineoplastic Agents, Hormonal; D005938:Glucocorticoids; D015282:Octreotide; D011241:Prednisone